Newsfeeds - Spark Newswire

1 minute read

Clene Reports Will Present Data From Phase 2 Multiple Sclerosis Programs At Americas Committee for Treatment and Research in Multiple Sclerosis Feb. 24, 2022

Today, 4:10 AM

Clene Inc. (NASDAQ:CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of

CLNN

1 minute read

News

Clene Nanomedicine Provides Clinical Program Update

By Benzinga Newsdesk

Today, 4:10 AM

Healey ALS Platform Trial fully enrolled; top-line data expected 2H 2022 Significant survival benefit from RESCUE-ALS open label extension (OLE) Phase 2 trial to be presented at upcoming Muscular Dystrophy

CLNN

10 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 4:10 AM

During Thursday's morning trading, 152 companies set new 52-week lows.

ADTX

1 minute read

Clene Nanomedicine’s Second Asset, CNM-ZnAg, Completes 50% Patient Enrollment In COVID-19 Trial

By Benzinga Newsdesk

Today, 4:10 AM

Clene Inc. (NASDAQ:CLNN) along with its subsidiaries "Clene" and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced it has enrolled more

CLNN

25 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 4:10 AM

During Friday's session, 445 companies made new 52-week lows.

AAOI

4 minute read

48 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:10 AM

Gainers Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday. MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58.

BBIG

4 minute read

59 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:10 AM

Gainers SeaChange International, Inc. (NASDAQ: SEAC) jumped 128.8% to $1.72 following Bloomberg report suggesting that social video app Triller is in merger talks with Seachange.

ALLO

3 minute read

40 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 4:10 AM

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.

ALXO